Your Cart

Quantity Products|Value Products

category information shipping & payment
  • img img2 img3 img4 img5
  • gls


  • Oxanabol
    Name Oxanabol
    Price 40.00 €
    Aviliable dostępny
    Manufacturer British Dragon, Thailand
    Volume 100 tablets


    Quantity Quantity.


    Substantion: Oxandrolone

    Manufacturer: British Dragon Pharmaceuticals

    Pack: 100 tablets 10mg/tabl

    Active Life: 8-12 hours

    Drug Class: Anabolic/Androgenic Steroid (Oral)

    Average Dose: Men 20-50 mg/day......Women 5-15 mg/day

    Acne: Only in higher doses

    Water Retention: Rare

    High Blood Pressure: Rare

    Liver Toxic: Yes, c17-alfa-alkylated steroid. Due to low doses, toxicity is low to medium

    Aromatization: None

    DHT Conversion: Low

    Decrease HPTA function: Dose depandant

    Oxandrolone is a 17-alpha-alkylated oral anabolic steroid.  Oxandrolone has an excellent myotrophic activity index of 3.2 and a low androgenic activity index of 0.2. At low doses, oxandrolone will not cause suppression of endogenous testosterone production and does not aromatize to estrogens.

    Oxandrolone was approved for treating alcoholic hepatitis, Turner’s syndrome, and weight loss caused by HIV. In addition, the drug has shown positive results in treating anemia and hereditary angioedema and for preserving muscle mass in burns patients.  Oxandronolne also has been used with good success for idiopathic muscle mass loss and osteoporosis. At low dose (5-10mg), oxandrolone binds weakly to androgen receptors and therefore can be used by woman and does not cause virilisation. Oxandrolone has a half life 10-13 hours.

    Dosage and administration:
    Geriatric use:  at daily doses of 5- 10 mg proved to be safe for up 4 months of continuous use.

    Adverse reactions:
    Hepatic: Cholestatic jaundice. Hepatocellular neoplasms and peliosis hepatis with long-term therapy. Reversible changes in liver function tests also occur. In females:  Clitoral enlargement, menstrual irregularities.

    Drug interactions:
    Anabolic steroids may increase sensitivity to oral anticoagulants. Dosage of the anticoagulant may have to be decreased in order to maintain desired prothrombin time. Patients receiving oral anticoagulant therapy require close monitoring, especially when anabolic steroids are started or stopped.

    Oxandrolone may inhibit the metabolism of oral hypoglycemic agents.

    Known or suspected carcinoma of the prostate or the male breast.
    Carcinoma of the breast in females with hypercalcemia (androgenic anabolic steroids may stimulate osteolytic bone resorption). Pregnancy.